While we have shown that blocking eCIRP’s effect on the TLR4-MD2 complex attenuates the fibrotic effect of bleomycin, we have not directly assessed whether this comes as a result of blocking the inflammatory phase of bleomycin-induced pulmonary fibrosis as speculated. The gene discussed is LY96; the disease is pulmonary fibrosis.